More SEC Filings
View Older Stories View Newer Stories-
Form 10-Q Bally's Corp For: Jun 30
-
Form 13F-HR ELEMENT CAPITAL MANAGEME For: Jun 30
-
Form 13F-NT Galaxy Digital Trading For: Jun 30
-
Form 13F-NT Galaxy Digital LLC For: Jun 30
-
Form 13F-NT Galaxy Digital GP LLC For: Jun 30
-
Form 13F-HR WFA of San Diego, LLC For: Jun 30
-
Form 13F-HR Galaxy Digital Capital For: Jun 30
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form D/A EagleOne Primaries (Caym
-
Form ABS-15G DoubleLine Mortgage Oppo
-
Form SCHEDULE 13G/A Anteris Technologies Filed by: Nantahala Capital Management, LLC
-
Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: Nextech Crossover I GP S.a r.l.
-
Form 424B2 UBS AG
-
Form DEFA14A InPoint Commercial Real
-
Form 424B2 UBS AG
-
Form ABS-15G Grand Avenue Mortgage
-
Form 497K Themes ETF Trust
-
Form SCHEDULE 13G/A KIORA PHARMACEUTICALS Filed by: Nantahala Capital Management, LLC
-
Form 424B2 UBS AG
-
Form N-PX Sageworth Trust Co For: Jun 30
-
Form NPORT-P Oxford Lane Capital Corp For: Jun 30
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form 424B2 UBS AG
-
Form SCHEDULE 13G/A Tyra Biosciences, Inc. Filed by: NEXTECH VI ONCOLOGY SCSP
-
Form SCHEDULE 13G/A PELOTON INTERACTIVE, Filed by: Nantahala Capital Management, LLC
-
Form SCHEDULE 13G/A Edgewise Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form 425 Essential Utilities, Filed by: Essential Utilities, Inc.
-
Form 424B3 Agassi Sports Entertainm
-
Form SCHEDULE 13G/A GEOSPACE TECHNOLOGIES Filed by: DISCIPLINED GROWTH INVESTORS INC /MN
-
Form 424B3 Cantor Fitzgerald Income
-
Form 424B2 UBS AG
-
Form SCHEDULE 13G/A Karyopharm Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form 497K Themes ETF Trust
-
Form SCHEDULE 13G/A Velo3D, Inc. Filed by: AWM Investment Company, Inc.
-
Form 424B2 UBS AG
-
Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: Caligan Partners LP
-
Form 424B2 UBS AG
-
Form 424B2 Jefferies Financial Grou
-
Form N-PX CHICKASAW CAPITAL MANAGE For: Jun 30
-
Form SCHEDULE 13G/A TELA Bio, Inc. Filed by: Nantahala Capital Management, LLC
-
Form SCHEDULE 13G/A CervoMed Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form SCHEDULE 13G/A Inhibikase Therapeutics, Filed by: Nantahala Capital Management, LLC
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form N-PX STANCE CAPITAL LLC For: Jun 30
